doi: 10.1208/s12249-023-02501-2 229 ToumiEGoutorbeBPlauzollesABonnetMMezouarSMilitelloMet al
This marked it as the first dual GLP-1 and GIP receptor agonist for this purpose
- Patients who cannot receive injections (kids, needle-phobic, traveling, etc.)
However, succinate has been also regarded as a detrimental metabolite in ischemia-reperfusion injury due to its rapid oxidation at the onset of tissue reperfusion, which drives reactive oxygen species generation and necrotic cell death 58
Theoretical Risks with Chronic Use Some concerns raised by clinicians and researchers include: Unregulated angiogenesis: Overstimulation of blood vessel growth could hypothetically support tumor progression in cancer-prone individuals Unknown hormonal crosstalk: While BPC-157 is non-hormonal, it interacts with systems (e.g., nitric oxide, dopamine) that may influence downstream signaling Immune tolerance or desensitization: Chronic exposure to any peptide could alter immune recognition or receptor sensitivity over time These concerns are theoretical , but they highlight why BPC-157 should not be used indefinitely or in uncontrolled cycles
Ipamorelin is a key peptide in muscle growth , fat loss , and anti-aging research due to its ability to promote GH secretion without undesirable side effects